Benzinga  Dec 18  Comment 
Analysts at Roth Capital downgraded Volcano Corporation (NASDAQ: VOLC) from Buy to Neutral. The price target for Volcano has been raised from $16 to $18. Volcano shares have dropped 15.93% over the past 52 weeks, while the S&P 500 index has...
Benzinga  Dec 18  Comment 
Benzinga  Dec 17  Comment 
Volcano Corporation (NASDAQ: VOLC) is unlikely to attract a sweeter deal than the one it agreed to Wednesday with Royal Philips, according to a couple of analysts. Volcano, which makes surgical tools for angioplasty, inked a $1 billion deal...
Motley Fool  Dec 17  Comment 
The beleaguered device-maker's fortunes turned around quickly with the arrival of a white knight from Europe.
TheStreet.com  Dec 17  Comment 
NEW YORK (TheStreet) -- Volcano shares are up 55.2% to $17.83 on extremely heavy volume on Wednesday after the precision medical device manufacturer was purchased by Philips  for $1.2 billion today. Philips, the diversified manufacturer...
Benzinga  Dec 9  Comment 
Analysts at Needham upgraded Volcano (NASDAQ: VOLC) from Hold to Buy. The price target for Volcano is set to $13. Volcano shares have dropped 52.38% over the past 52 weeks, while the S&P 500 index has gained 14.30% in the same...
TheStreet.com  Nov 17  Comment 
NEW YORK (TheStreet) -- Shares of Volcano Corp. are up 3.5% to $11.30 after Credit Suisse upgraded the company to "outperform" from "neutral" while lowering its price target to $14 from $16. The San Diego-based developer of precision guided...
Benzinga  Nov 17  Comment 
In a report published Monday, Credit Suisse analyst Bruce Nudell upgraded the rating on Volcano Corporation (NASDAQ: VOLC) from Neutral to Outperform, but lowered the price target from $16.00 to $14.00. In the report, Credit Suisse noted, “Our...
TheStreet.com  Oct 2  Comment 
NEW YORK (TheStreet) --aVolcano was gaining 10.2% to $11.34 on heavy trading volume Thursday after Camber Capital Management disclosed a 9.81% stake in the medical device maker. The investment firm said that it believes shares of Volcano are...


Volcano Corporation designs, develops, manufactures, and commercializes a broad suite of intravascular ultrasound, or IVUS, and functional measurement, or FM, products that it believes enhance the diagnosis and treatment of vascular and structural heart disease. The IVUS products consist of consoles, single-procedure disposable catheters, and advanced functionality options. The family of consoles includes the IVUS In-Vision Gold or IVG and the new PC-based s5, which became the primary console following its full commercial launch in mid-2006. During an IVUS procedure, an imaging catheter is placed inside an artery to produce a cross-sectional image of the size and shape of the artery's lumen and provides information concerning the composition and density of plaque or lesions and the condition of the layers of the surrounding arterial walls. As a part of the vfusion cath lab integration initiative, the company has developed customized cath lab versions of these consoles and is developing advanced functionality options. FM products consist of pressure and flow consoles and single-procedure disposable pressure and flow guide wires. These FM consoles also include a cath lab version. FM devices measure the pressure and flow characteristics of blood around plaque thereby allowing physicians to gauge the plaque s impact on blood flow and pressure. Based on product, IVUS consoles, FM consoles, disposable catheters, disposable guide wires, and other contributed 21%, 2%, 64%, 10%, and 3%, respectively, to 2006 revenue. Other revenue consist primarily of spare parts sales, service and maintenance revenues, shipping and handling revenues, and license fees. Based on geography, the U.S. and Japan contributed 50% and 29% respectively while Europe, Middle East, & Africa and rest of world contributed 17% and 4% respectively to total 2006 revenue. The company completed its initial public offering of common stock on June 15, 2006.


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki